A Phase II, Double Blind, Placebo Controlled, Randomised Study to Assess the Efficacy and Safety of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients Who Have Failed Therapy With an Oxaliplatin and Fluoropyrimidine Containing Regimen
Latest Information Update: 29 Jul 2019
Price :
$35 *
At a glance
- Drugs Vandetanib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Genzyme Corporation
- 14 Apr 2009 Planned end date (May 2009) added as reported by ClinicalTrials.gov.
- 17 Jan 2009 Primary endpoint results presented at ASCO-GCS
- 11 May 2008 The actual completion date for this trial is Apr 2008